tiprankstipranks
Trending News
More News >
Lophos Holdings, Inc. (TSE:MESC)
:MESC
Canadian Market
Advertisement

Lophos Holdings, Inc. (MESC) Price & Analysis

Compare
2 Followers

MESC Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

4.78%95.22%
Mutual Funds
― Other Institutional Investors
95.22% Public Companies and
Individual Investors

MESC FAQ

What was Lophos Holdings, Inc.’s price range in the past 12 months?
Lophos Holdings, Inc. lowest stock price was C$0.01 and its highest was C$0.03 in the past 12 months.
    What is Lophos Holdings, Inc.’s market cap?
    Lophos Holdings, Inc.’s market cap is C$858.60K.
      When is Lophos Holdings, Inc.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Lophos Holdings, Inc.’s earnings last quarter?
      Currently, no data Available
      Is Lophos Holdings, Inc. overvalued?
      According to Wall Street analysts Lophos Holdings, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Lophos Holdings, Inc. pay dividends?
        Lophos Holdings, Inc. does not currently pay dividends.
        What is Lophos Holdings, Inc.’s EPS estimate?
        Lophos Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Lophos Holdings, Inc. have?
        Lophos Holdings, Inc. has 85,859,670 shares outstanding.
          What happened to Lophos Holdings, Inc.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Lophos Holdings, Inc.?
          Currently, no hedge funds are holding shares in TSE:MESC

          Company Description

          Lophos Holdings, Inc.

          Lophos Holdings Inc. se rapporte à la culture et à la recherche de Lophophora williamsii (« cactus peyotl »). De plus, à long terme, la Société est engagée dans la recherche et le développement de composés dérivés du cactus peyotl. La filiale en propriété exclusive de la société, Lophos Pharmaceuticals Corp., est une société de biosciences spécialisée dans la culture, la recherche et la vente de cactus peyotl. Elle est également autorisée à posséder, produire, vendre/fournir, envoyer, transporter et livrer les substances contrôlées couvertes par sa licence de revendeur de substances contrôlées (CSDL), à savoir la mescaline, la psilocine et la psilocybine.
          Similar Stocks
          Company
          Price & Change
          Follow
          Albert Labs International
          ChitogenX
          Waverley Pharma
          HAVN Life Sciences
          Lexston Life Sciences Corp.
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis